DWA
CRDF icon

Dorsey Wright & Associates’s Cardiff Oncology CRDF Stock Holding History

Dorsey Wright & Associates’s Portfolio CRDF Stock Details CRDF Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,701
Closed -$24K – 328
2020
Q3 		$24K Buy
+1,701
New +$11.2K ﹤0.01% 152

Other funds holding CRDF

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CC
Caxton Corporation Princeton, New Jersey $4.02M AUM 256.08% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $9.53M AUM 805.26% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Dorsey Wright & Associates's CRDF Position: Q4 2020 in Review

Dorsey Wright & Associates sold out of Cardiff Oncology (CRDF) in Q4 2020, closing a stake of 1,701 shares — an estimated $24K sold.

Dorsey Wright & Associates first reported a position in CRDF in Q3 2020 and held it in 1 quarter. The position peaked at $24K in Q3 2020. 82 funds tracked by Wall St. Rank hold CRDF as of Q4 2020.

  • Dorsey Wright & Associates reported no remaining Cardiff Oncology position as of Q4 2020 after selling out during the quarter.
  • Dorsey Wright & Associates sold 1,701 Cardiff Oncology shares in Q4 2020, an estimated $24K.
  • Dorsey Wright & Associates first reported a position in Cardiff Oncology in Q3 2020 and held it in 1 quarter.
  • Dorsey Wright & Associates's Cardiff Oncology position peaked at $24K in Q3 2020.
  • 82 funds tracked by Wall St. Rank held Cardiff Oncology as of Q4 2020.

Based on Dorsey Wright & Associates's 13F filing for Q4 2020, filed 28 Jan 2021.